Unfortunately, standard care for T1D has not changed since the discovery of insulin 100 years ago and mostly revolves around treating T1D with exogenous insulin following clinical presentation of hyperglycemia which is considered a fasting blood glucose concentration above 126 mg·dL−1 or random blood glucose concentration above 200 mg·dL−1 [2]. Here, INS is linked to Hyperglycemia.